Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 112020 | 1.94 |
09:34 ET | 7095 | 1.95 |
09:36 ET | 14835 | 1.97 |
09:38 ET | 5000 | 1.96 |
09:39 ET | 76251 | 1.95 |
09:41 ET | 29257 | 1.935 |
09:43 ET | 9482 | 1.94 |
09:45 ET | 13706 | 1.935 |
09:48 ET | 22386 | 1.9399 |
09:50 ET | 93166 | 1.915 |
09:52 ET | 20731 | 1.9 |
09:54 ET | 33705 | 1.92 |
09:56 ET | 50966 | 1.915 |
09:57 ET | 60490 | 1.89 |
09:59 ET | 34303 | 1.9002 |
10:01 ET | 81550 | 1.9307 |
10:03 ET | 52313 | 1.935 |
10:06 ET | 54629 | 1.93 |
10:08 ET | 2636 | 1.91 |
10:10 ET | 12853 | 1.9 |
10:12 ET | 27552 | 1.895 |
10:14 ET | 37716 | 1.905 |
10:15 ET | 12773 | 1.905 |
10:17 ET | 38060 | 1.88 |
10:19 ET | 30393 | 1.8886 |
10:21 ET | 3547 | 1.88 |
10:24 ET | 16074 | 1.8899 |
10:26 ET | 88071 | 1.865 |
10:28 ET | 203303 | 1.87 |
10:30 ET | 34952 | 1.865 |
10:32 ET | 118514 | 1.865 |
10:33 ET | 3600 | 1.865 |
10:35 ET | 1774 | 1.86 |
10:37 ET | 5726 | 1.8627 |
10:39 ET | 12413 | 1.86 |
10:42 ET | 2674 | 1.8681 |
10:44 ET | 10469 | 1.86 |
10:46 ET | 7486 | 1.8687 |
10:48 ET | 5118 | 1.86 |
10:50 ET | 8425 | 1.865 |
10:51 ET | 7647 | 1.865 |
10:53 ET | 2251 | 1.86 |
10:55 ET | 58806 | 1.855 |
10:57 ET | 6213 | 1.865 |
11:00 ET | 4917 | 1.86 |
11:02 ET | 17840 | 1.87 |
11:04 ET | 9151 | 1.865 |
11:06 ET | 2100 | 1.86 |
11:08 ET | 3220 | 1.87 |
11:09 ET | 5566 | 1.865 |
11:11 ET | 62893 | 1.86 |
11:13 ET | 13504 | 1.86 |
11:15 ET | 8535 | 1.8682 |
11:18 ET | 4600 | 1.86 |
11:20 ET | 45743 | 1.91 |
11:22 ET | 19766 | 1.905 |
11:24 ET | 9297 | 1.905 |
11:26 ET | 13328 | 1.895 |
11:27 ET | 4500 | 1.89 |
11:29 ET | 130010 | 1.885 |
11:31 ET | 5651 | 1.88 |
11:33 ET | 2928 | 1.88 |
11:36 ET | 3298 | 1.885 |
11:38 ET | 15699 | 1.895 |
11:40 ET | 4216 | 1.8999 |
11:42 ET | 32018 | 1.895 |
11:44 ET | 20334 | 1.89 |
11:45 ET | 20005 | 1.89 |
11:47 ET | 3686 | 1.895 |
11:49 ET | 22351 | 1.895 |
11:51 ET | 3581 | 1.89 |
11:54 ET | 3015 | 1.895 |
11:56 ET | 3330 | 1.89 |
11:58 ET | 1000 | 1.89 |
12:00 ET | 1764 | 1.895 |
12:02 ET | 4655 | 1.895 |
12:03 ET | 1400 | 1.89 |
12:05 ET | 2642 | 1.89 |
12:07 ET | 13439 | 1.89 |
12:09 ET | 17242 | 1.8901 |
12:12 ET | 2970 | 1.895 |
12:14 ET | 1901 | 1.895 |
12:16 ET | 6939 | 1.89 |
12:18 ET | 8878 | 1.89 |
12:20 ET | 2606 | 1.89 |
12:21 ET | 2200 | 1.895 |
12:23 ET | 950 | 1.89 |
12:25 ET | 1595 | 1.89 |
12:27 ET | 16165 | 1.905 |
12:30 ET | 2487 | 1.9082 |
12:32 ET | 6904 | 1.905 |
12:34 ET | 1447 | 1.91 |
12:36 ET | 9360 | 1.915 |
12:38 ET | 9503 | 1.925 |
12:39 ET | 2512 | 1.9205 |
12:41 ET | 1100 | 1.9211 |
12:43 ET | 1719 | 1.925 |
12:45 ET | 3937 | 1.9277 |
12:48 ET | 410 | 1.925 |
12:50 ET | 1769 | 1.925 |
12:52 ET | 400 | 1.93 |
12:54 ET | 600 | 1.93 |
12:56 ET | 1578 | 1.93 |
12:57 ET | 12919 | 1.925 |
12:59 ET | 18200 | 1.925 |
01:01 ET | 680 | 1.925 |
01:03 ET | 2333 | 1.93 |
01:06 ET | 1628 | 1.93 |
01:08 ET | 12769 | 1.94 |
01:10 ET | 1019 | 1.9318 |
01:12 ET | 10037 | 1.95 |
01:14 ET | 5140 | 1.95 |
01:15 ET | 5043 | 1.95 |
01:17 ET | 1000 | 1.95 |
01:19 ET | 3290 | 1.945 |
01:21 ET | 11912 | 1.945 |
01:24 ET | 5603 | 1.935 |
01:26 ET | 2686 | 1.94 |
01:28 ET | 18219 | 1.932 |
01:30 ET | 2000 | 1.935 |
01:32 ET | 600 | 1.935 |
01:33 ET | 8895 | 1.935 |
01:35 ET | 23210 | 1.925 |
01:37 ET | 611 | 1.9225 |
01:39 ET | 1069 | 1.925 |
01:42 ET | 30753 | 1.925 |
01:44 ET | 2600 | 1.92 |
01:46 ET | 4459 | 1.92 |
01:48 ET | 4390 | 1.925 |
01:50 ET | 13409 | 1.915 |
01:51 ET | 3250 | 1.9103 |
01:53 ET | 18632 | 1.905 |
01:55 ET | 4221 | 1.9003 |
01:57 ET | 5280 | 1.9 |
02:00 ET | 1600 | 1.905 |
02:02 ET | 970 | 1.905 |
02:04 ET | 200 | 1.9 |
02:06 ET | 1600 | 1.905 |
02:08 ET | 2271 | 1.9016 |
02:09 ET | 3300 | 1.9085 |
02:11 ET | 1875 | 1.9 |
02:13 ET | 14330 | 1.9 |
02:15 ET | 5592 | 1.905 |
02:18 ET | 2858 | 1.9087 |
02:20 ET | 9800 | 1.905 |
02:22 ET | 13927 | 1.895 |
02:24 ET | 2680 | 1.895 |
02:26 ET | 3492 | 1.895 |
02:27 ET | 400 | 1.895 |
02:29 ET | 989 | 1.9 |
02:31 ET | 9967 | 1.905 |
02:33 ET | 1200 | 1.905 |
02:36 ET | 7675 | 1.915 |
02:38 ET | 1429 | 1.92 |
02:40 ET | 1300 | 1.915 |
02:42 ET | 1100 | 1.92 |
02:44 ET | 910 | 1.92 |
02:45 ET | 21553 | 1.925 |
02:47 ET | 3500 | 1.925 |
02:49 ET | 6508 | 1.91 |
02:51 ET | 2201 | 1.915 |
02:54 ET | 200 | 1.91 |
02:56 ET | 6383 | 1.915 |
02:58 ET | 10338 | 1.905 |
03:00 ET | 1437 | 1.91 |
03:02 ET | 1040 | 1.9 |
03:03 ET | 25560 | 1.9 |
03:05 ET | 2900 | 1.905 |
03:07 ET | 1712 | 1.905 |
03:09 ET | 17935 | 1.905 |
03:12 ET | 5388 | 1.9199 |
03:14 ET | 753 | 1.92 |
03:16 ET | 950 | 1.92 |
03:18 ET | 8989 | 1.915 |
03:20 ET | 12298 | 1.915 |
03:21 ET | 6900 | 1.915 |
03:23 ET | 3402 | 1.915 |
03:25 ET | 1784 | 1.915 |
03:27 ET | 2806 | 1.92 |
03:30 ET | 1475 | 1.915 |
03:32 ET | 780 | 1.92 |
03:34 ET | 9445 | 1.93 |
03:36 ET | 3495 | 1.93 |
03:38 ET | 11010 | 1.94 |
03:39 ET | 3300 | 1.94 |
03:41 ET | 24528 | 1.92 |
03:43 ET | 1455 | 1.925 |
03:45 ET | 5392 | 1.925 |
03:48 ET | 5143 | 1.93 |
03:50 ET | 12827 | 1.925 |
03:52 ET | 16766 | 1.925 |
03:54 ET | 12759 | 1.93 |
03:56 ET | 55690 | 1.905 |
03:57 ET | 49095 | 1.905 |
03:59 ET | 118394 | 1.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 147.3M | 9.6x | --- |
Spero Therapeutics Inc | 85.7M | 3.8x | --- |
2Seventy Bio Inc | 246.7M | -1.1x | --- |
Rigel Pharmaceuticals Inc | 166.7M | -8.4x | --- |
Alimera Sciences Inc | 167.6M | -1.5x | --- |
Seres Therapeutics Inc | 139.3M | -1.5x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $147.3M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.17 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 9.6x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | 7.9x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.